Real Numbers
1.3 Absolute value and bounded functions Note: 0.5–1 lecture
80
early onset GBS disease. GBS though an uncommon problem in postpartum women should still be considered a cause of postpartum complications such as postpartum endometritis.
The implication of this study on future research is the need for the development of an antibiogram adapted to our local environment to enhance the efficiency of interim empirical treatment that has an almost uniformly good outcome with early antimicrobial therapy for this otherwise fulminant infection.
It would also be pertinent to explore the serotype distribution of GBS in this environment to check for their clinical correlates in a bid to find out why only some of the colonized clients manifest morbidity and mortality.
81
(as a surrogate for intrapartum screening) for recto-vaginal colonization by GBS and selective intrapartum antibiotic prophylaxis.
3) Local antibiogram and culture sensitivity profiles should be established for GBS to enhance empirical treatment of suspected GBS infections while awaiting isolation and antibiotic sensitivity testing.
4) Other well planned prospective randomized studies are desired to validate the findings of this study and the efficacy in our peculiar environment of solutions already being used elsewhere.
5) Studies screening all neonatal unit admissions for GBS should be encouraged as they will provide complementary information regarding the burden of GBS among children born outside the hospital setting and its overall implications on neonatal unit admissions and expenditure.
6) Studies are required to look at the survivors of neonatal GBS disease to quantify in our local environment the magnitude of permanent disabilities they suffer; such as, hearing deficit, visual loss and mental deficits on a backdrop of what has already been characterized in the literature from other parts of the world.
82
REFERENCES
1. UN Development Programme. MDG monitor: tracking the millennium development goals. [accessed Sept 1, 2008]. 2007 Error! Hyperlink reference not valid.
2. WHO. UNICEF. UNFPA. Maternal mortality in 2005. World Health Organization;
Geneva: 2007 The World Bank. http://www.who.int/reproductive-health/publications/maternal_mortality_2005/ mme_2005.pdf
3. UNICEF. Global progress in reducing child mortality is insufficient to reach MDG 4.
United Nations Children’s Fund; New York: 2008
http://www.unicef.org/sowc08/docs/Figure-1.6.pdf
4. Countdown Coverage Writing Group and on behalf of the Countdown to 2015 Core Group. Countdown to 2015 for maternal, newborn, and child survival: the 2008 report on tracking coverage of interventions. Lancet 2008;371:1247–58. [PubMed:
18406859]
5. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? where? why? Lancet 2005;365:891–900. [PubMed: 15752534]
6. Verani JR, McGee L, Schrag SJ. Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC 2010, MMWR. 2010; 59: 1 – 36.
7. Health Protection Agency. Incidence of Group B streptococcal disease in infants aged
less than 90 days old. CDR Weekly 2002;12(16):3.
[193.129.245.226/publications/cdr/archive02/News/news1602.html gpB]
8. Benitz WE, Gould JB, Druzin ML. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review. Pediatrics.1999 Jun;103(6):e77.
83
9. Barcaite E, Bartusevicius A, Tameliene R, Kliucinskas M, Maleckiene L, et al.
Prevalence of maternal group B streptococcal colonization in European countries. Acta Obstet Gynecol Scand. 2008; 87 (3): 260-71.
10. Stoll BJ, Schuchat A. Maternal carriage of group B streptococci in developing countries. Pediatr Infect Dis J 1998; 17:6: 499-503.
11. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al.
Epidemiology of invasive group B streptococcal disease in the United States, 1999–
2005. JAMA 2008;299:2056–65.
12. Krohn MA, Hillier SL, Baker CJ. Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis 1999;179:1410–5.
13. Persson K, Christensen KK, Christensen P, Forsgren A, Jorgensen C, Persson PH.
Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand J Infect Dis 1985;17:195–9.
14. Wood EG, Dillon HC. A prospective study of group B streptococcal bacteriuria in pregnancy. Am J Obstet Gynecol 1981;140:515–20.
15. Pass MA, Gray BM, Dillon HC. Puerperal and perinatal infections with group B streptococci. Am J Obstet Gynecol 1982;143:147–52.
16. Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 1994;84:816–9.
17. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington J, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, 1995:980–1054.
84
18. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. In: CDC surveillance summaries (November 20). MMWR 1992;41(No. SS-6):25–32.
19. Desa DJ, Trevenen CL. Intrauterine infections with group B beta-haemolytic streptococci. Br J Obstet Gynaecol 1984;91:237–9.
20. Katz V, Bowes WA Jr. Perinatal group B streptococcal infections across intact amniotic membranes. J Reprod Med 1988;33:445–9.
21. Franciosi RA, Knostman JD, Zimmerman RA. Group B streptococcal neonatal and infant infections. J Pediatr 1973;82:707–18.
22. Baker CJ. Early onset group B streptococcal disease. J Pediatr 1978;93:124–5.
23. Centers for Disease Control and Prevention. Prevention of group B streptococcal disease: A public health perspective. MMWR Morb Mortal Wkly Rep 1996;45(RR-7):1–24.
24. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al.
Group B streptococcal disease in the era of intra-partum antibiotic prophylaxis. N Engl J Med 2000;342:15–20. [PubMed: 10620644].
25. CDC. Perinatal group B streptococcal disease after universal screening recommendations—United States, 2003–2005. MMWR 2007;56: 701–5.
26. Gray KJ, Bennett SL, French N. Invasive group B Streptococcal infection in infants, Malawi. Emerg Infect Dis 2007;13(2):223–9. [Medline]
27. Smaill F, Hofmeyr GJ. Antibiotic prophylaxis for caesarean section. Cochrane Database Syst Rev 2002;3:CD000933. [PubMed: 12137614]
28. Lawn JE, Rudan I, Rubens C. Four million newborn deaths: is the global research agenda evidence-based? Early Hum Dev 2008;84:809–14. [PubMed: 18829188]
85
29. Rosenstein N, Schuchat A. Neonatal GBS Disease Study Group. Opportunities for prevention of perinatal group B streptococcal disease: A multistate surveillance analysis. Obstet Gynecol 1997; 90:901– 6.
30. Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233–9.
31. Illuzzi JL, Bracken MB. Duration of intra-partum prophylaxis for neonatal group B streptococcal disease: a systematic review. Obstet Gynecol 2006;108:1254–65.
32. Barber EL, Zhao G, Buhimschi IA, Illuzzi JL. Duration of intra-partum prophylaxis and concentration of penicillin G in fetal serum at delivery. Obstet Gynecol 2008;112(2 Pt 1):265–70.
33. de Cueto M, Sanchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M.
Timing of intra-partum ampicillin and prevention of vertical transmission of group B Streptococcus. Obstet Gynecol 1998;91:112–4.
34. Lin FY, Brenner RA, Johnson YR, et al. The effectiveness of risk-based intra-partum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol 2001;184:1204–10.
35. Stray-Pederson B. Economic evaluation of maternal screening to prevent congenital syphilis. Sex Transm Dis 1983; 10:167–72.
36. Heath PT, Feldman RG. Vaccination against group B Streptococcus. Expert Review of Vaccines 2005; 4:207–18.
37. Moyo RS. Studies on Streptococcus agalactiae surface anchored markers with emphasis on strains and human sera from Zimbabwe. Ph.D. Thesis. Norwegian University of Science and Technology, 2002; pp45-48
86
38. Dzowela T, Komolafe OO, Igbigbi A. Prevalence of Group B Strepococcus colonization in antenatal women at the Queen Elizabeth Central Hospital, Blantyre-A Preliminary Study. Malawi Medical Journal, 2005; 17 (3): 97-99
39. Locksmith GJ, Clark P, Duff P. Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease. Am J Obstet Gynecol 1999;180:416–22.
40. Adedeji BAM. and Abdulkadir OA, 2009. Etiology and antimicrobial resistance pattern of bacterial agents of urinary tract Infections in students of tertiary Institutions in Yola Metropolis. Advances in Biological Research 3 (3-4): 67-70
41. Regan JA, Klebanoff MA, Nugent RP. The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 1991;77:604–10.
42. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 2000 Oct;96(4):498–503.
43. Boyer KM, Gotoff SP. Strategies for chemoprophylaxis of GBS early-onset infections.
Antibiot Chemother 1985;35:267–80.
44. Yancey MK, Schuchat A, Brown LK, Ventura VL, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811–5.
45. Hastings MJ, Easmon CS, Neill J, Bloxham B, Rivers RP. Group B streptococcal colonisation and the outcome of pregnancy. Journal of Infection 1986;12:23–9.
46. Kowalska B, Niemiec KT, Drejewicz H,Polak K, Kubik P, et al. Prevalence of group B streptococcal colonization in pregnant women and their newborns based on the results of examination of patients in the obstetric and Gynecology Department of
87
National Research Institute of Mother and Child- a pilot study.Ginekologia Polska 2003; 74 (10): 1223-7.
47. Uhiara JE. Group B streptococcal carriage among parturients and their neonates in Zaria, Nigeria. Afr.J. med. and med. Sc. 10/1993; 22(3):79-83.
48. Nwachukwu N, Utsalo SJ, Kanu I, Anyanwu E. Genital Colonization of Group B Streptococcus at term pregnancy in Calabar, Nigeria. The Internet Journal of Pediatrics and Neonatology. 2007; 7(2): ISSN: 1528-8374.
49. Dawodu AH, Damole IO, Onile BO. Epidemiology of group B streptococcal carriage among pregnant women and their neonates: an African experience. Trop Geogr Med.
1983 Jun;35(2):145-50.
50. Donbraye-Emmanuel OOB, Okonko IO, Donbraye E, Fadeyi A, Abubakar MJ.
Isolation and characterization of Group B Streptococci and other pathogens among pregnant women in Ibadan, Southwestern Nigeria. J. Appl. Biosci. 2010; 29: 1781 – 1792.
51. Onipede A, Adefusi O, Adeyemi A, Adejuyigbe E, Oyelese A, et al. Group B Streptococcus carriage during late pregnancy in Ile-Ife, Nigeria. Afr. J. Cln. Exper.
Microbiol. 2012; 13(3): 135-143.
52. Biobaku OR, Olaleye AO, Adefusi OF, Adeyemi AB, Onipede AO et. al. Group B Streptococcus colonization and HIV in pregnancy: A cohort study in Nigeria. J Neonatal Perinatal Med. 10 (2017) 91–97.
53. Petts DN, Colistin-Oxolinic Acid-blood agar: a new selective medium for Streptococci.
J Clinical Microbiol, Jan. 1984, p. 4-7.
54. Bello, OO. Kehinde, AO. Oluwasola, TAO. Odukogbe, AA. Prevalence of recto-vaginal Group B Streptococcus (GBS), among pregnant women at University College Hospital, Ibadan, Nigeria. Trop. J. Obstet. Gynaecol.33 (1) 2016:21-26.
88
55. Poisson DM, Chandemerle M, Guinard J, Frenaux C, Guigon A, Bret L, Mesnard L.
Prepartum antibio prophylaxis: comparison of Group B Streptococcus detection rates of two chromogenic media and blood agar for its isolation in pregnant women vaginal swabs. Scientific Poster 2010.
56. Poisson DM, Evrard ML,Freneaux C, Vives MI, Mesnard L. Evaluation of CHROMagarTM StrepB agar, an aerobic chromogenic medium for prepartum vaginal/rectal Group B Streptococcus screening. J. Microbiol. Methods. 2011(84):238-241.
57. Poisson DM, Evrard ML. Prepartum vaginal/anorectal Group B Streptococcus screening: improvement of the enrichment step by the broth additive RambaQUICK StrepB.J Microbiol Methods 89:107-9. 2012.
58. Fidanoski B. Staphylococcus versus Streptococcus: a comprehensive analysis.
Comparison and contrast. Textbook of Microbiology for postgraduates. 7th ed.
Philadelphia: Elsevier, 2015, 417-467.
59. World Health Organization (WHO). 1999. Conclusions from the WHO multicenter study of serious infections in young infants. The WHO Young Infants Study Group.
Pediatrics Infectious Disease Journal 18:S32–34.
60. Omoregie R, Egbe C A, Dirisu J, Ogefere OH, “Microbiology of neonatal septicemia in a tertiary hospital in Benin City, Nigeria,” Biomarkers and Genomic Medicine, vol.5, no. 4, pp. 142-146, 2013.
61. Boyer KM, Gadzala CA, Burd LI, Fisher DE, Paton JB, Gotoff SP. Selective intra-partum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I.
Epidemiologic rationale. J Infect Dis 1983;148:795–801.
62. Boyer KM, Gotoff SP. Antimicrobial prophylaxis of neonatal group B streptococcal sepsis.Clin Perinatol 1988;15:831–50.
89
63. Schuchat A, Zywicki S, Dinsmoor MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: a multicenter casecontrol study. Pediatrics 2000;105:21–6.
64. Oddie S, Embleton ND. Risk factors for early onset neonatal group B streptococcal sepsis: case-control study. BMJ (Clinical research ed 2002;325(7359):308.
65. Pass MA, Khare S, Dillon HC. Twin pregnancies: incidence of group B streptococcal colonization and disease. J Pediatr 1980;97:635–7.
66. Edwards MS, Jackson CV, Baker CJ. Increased risk of group B streptococcal disease in twins. JAMA 1981;245:2044–6.
67. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990; 162:672–7.
68. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill K, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994;13:623–9.
69. Seaward P, Gareth MB, Hannah ME, et al. International multicenter term prelabor rupture of membranes study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol 1997;177: 1024–29.
70. Adams WG, Kinney JS, Schuchat A, et al. Outbreak of early onset group B streptococcal sepsis. Pediat Infect Dis J 1993;12:565–70.
71. Soper DE, Mayhall CG, Froggatt JW. Characterization and control of intraamniotic infection in an urban teaching hospital. Am J Obstet Gynecol 1996;175:304–10.
72. Newton ER, Prihoda TJ, Gibbs RS. Logistic regression analysis of risk factors for intra-amniotic infection. Obstet Gynecol 1989;73:571–5.
90
73. Yancey MK, Duff P, Kubilis P, Clark P, Frentzen BH. Risk factors for neonatal sepsis.
Obstet Gynecol 1996;87:188–94.
74. Hibbard JU, Shashoua A, Adamczyk C, Ismail M. Cervical ripening with prostaglandin gel and hygroscopic dilators. Infect Dis Obstet Gynecol 1998;6:18–24.
75. Gibbs RS, Schrag S, Schuchat A. Perinatal infections due to group B streptococci.
Obstet Gynecol 2004;104(5 Pt 1):1062–76.
76. Adair CE, Kowalsky L, Quon H, et al. Risk factors for early-onset group B streptococcal disease in neonates: a population-based case-control study. CMAJ 2003;169:198–203.
77. Boulvain M, Stan C, Irion O. Membrane sweeping for induction of labour (Cochrane Review). In: The Cochrane Library, Issue 4. Oxford: 2001.
78. Boulvain M, Stan C, Irion O. Membrane sweeping for induction of labour. Cochrane database of systematic reviews (Online) 2005(1): CD000451.
79. Heinemann J, Gillen G, Sanchez-Ramos L, Kaunitz A. Do mechanical methods of cervical ripening increase infectious morbidity? A systematic review. Am J Obstet Gynecol 2008;199:177–87.
80. Ramus RM, McIntire DD, Wendel GD, Jr. Antibiotic chemoprophylaxis for group B strep is not necessary with elective cesarean section at term [Abstract]. Am J Obstet Gynecol 1999;180:S85.
81. Hakansson S, Axemo P, Bremme K, et al. Group B streptococcal carriage in Sweden:
a national study on risk factors for mother and infant colonisation. Acta Obstet Gynecol Scand 2008;87:50–8.
82. Christensen KK, Dahlander K, Linden V, Svenningsen N, Christensen P. Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A
91
prevention program based on bacteriological and immunological follow-up. Eur J Obstet Gynecol Reprod Biol 1981;12:143–50.
83. Carstensen H, Christensen KK, Grennert L, Persson K, Polberger S. Early-onset neonatal group B streptococcal septicaemia in siblings. J Infect 1988;17:201–4.
84. Faxelius G, Bremme K, Christensen KK, Christensen P, Ringertz S. Neonatal septicemia due to group B streptococci—perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 1988;16:423–30.
85. Cheng PJ, Chueh HY, Liu CM, Hsu JJ, Hsieh TT, Soong YK. Risk factors for recurrence of group B Streptococcus colonization in a subsequent pregnancy. Obstet Gynecol 2008;111:704–9.
86. Turrentine MA, Ramirez MM. Recurrence of group B streptococci colonization in subsequent pregnancy. Obstet Gynecol 2008;112 (2 Pt 1):259–64.
87. Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee MT, et al. Invasive disease due to group B streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis 2000;30:276–81.
88. Pass MA, Gray BM, Khare S, Dillon HC. Prospective studies of group B streptococcal infections in infants. J Pediatr 1979;95:431–43.
89. Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Lou Y, et al. Colonization with group B streptococci in pregnancy and adverse outcome: VIP Study Group. Am J Obstet Gynecol 1996;174:1354–60.
90. Heath PT, Balfour GF, Tighe H, Verlander NQ, Lamagni TL, Efstratiou A. Group B streptococcal disease in infants: a case control study. Arch Dis Child 2009;94:674–80.
91. Moller M, Thomsen AC, Borch K, Dinesen K, Zdravkovic M. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 1984;2(8394):69–70.
92
92. McKenna DS, Matson S, Northern I. Maternal group B streptococcal (GBS) genital tract colonization at term in women who have asymptomatic GBS bacteriuria.
Infectious diseases in Obstet Gynecol 2003;11(4):203–7.
93. Persson K, Bjerre B, Elfstrom L, Polberger S, Forsgren A. Group B streptococci at delivery: High count in urine increases risk for neonatal colonization. Scand J Infect Dis 1986;18:525–31.
94. CDC. Prevention of perinatal group B streptococcal disease: revised guidelines from CDC. MMWR 2002;51(No. RR-11).
95. Baecher L, Grobman W. Prenatal antibiotic treatment does not decrease group B Streptococcus colonization at delivery. Int J Gynaecol Obstet 2008;101:125–8.
96. Baker CJ, Edwards MS, Kasper DL. Role of antibody to native type III polysaccharide of group B streptococcus in infant infection. Pediatrics 1981;68:544–9.
97. Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child 2003;88:375–8.
98. Edwards MS. Group B streptococcal conjugate vaccine: a timely concept for which the time has come. Human Vaccines 2008;4:444–8.
99. Cochi SL, Feldman RA. Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight. Pediatr Infect Dis J 1983;2:414–5.
100. Dillon HC, Khare S, Gray BM. Group B streptococcal carriage and disease: a 6-year prospective study. J Pediatr 1987;110:31–6.
101. Easmon CSF, Hastings MJG, Clare AJ, et al. Nosocomial transmission of group B streptococci. Br Med J 1981;283:459–61.
102. Anthony BF, Okada DM, Hobel CJ. Epidemiology of the group B streptococcus:
maternal and nosocomial sources for infant acquisitions. J Pediatr 1979;95:431–6.
93
103. Yow MD, Leeds LJ, Mason EO, Clark DJ, Beachler CW. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. I. Colonization studies. Am J Obstet Gynecol 1980;137:34–8.
104. Hammerschlag MR, Baker CJ, Alpert S, et al. Colonization with group B streptococci in girls under 16 years of age. Pediatrics 1977;60:473–6.
105. Hansen SM, Uldbjerg N, Kilian M, Sorensen UB. Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol 2004;42:83–9.
106. Boyer KM, Gadzala CA, Kelly PD, Burd LI, Gotoff SP. Selective intra-partum chemoprophylaxis of neonatal group B streptococcal earlyonset disease. II. Predictive value of prenatal cultures. J Infect Dis 1983;148:802–9.
107. Badri MS, Zawaneh S, Cruz AC, et al. Rectal colonization with group B streptococcus:
relation to vaginal colonization of pregnant women. J Infect Dis 1977;135:308–12.
108. Quinlan JD, Hill DA, Maxwell BD, Boone S, Hoover F, Lense JJ. The necessity of both anorectal and vaginal cultures for group B Streptococcus screening during pregnancy. J Fam Pract 2000;49:447–8.
109. Kovavisarach E, Sa-adying W, Kanjanahareutai S. Comparison of combined vaginal-anorectal, vaginal and anorectal cultures in detecting of group B streptococci in pregnant women in labor. Journal of the Medical Association of Thailand [Chotmaihet thangphaet] 2007;90:1710–4.
110. Philipson EH, Palermino DA, Robinson A. Enhanced antenatal detection of group B streptococcal colonization. Obstet Gynecol 1995;85:437–9.
111. Orafu C, Gill P, Nelson K, Hecht B, Hopkins M. Perianal versus anorectal specimens:
is there a difference in group B streptococcal detection? Obstet Gynecol 2002;99:1036–
9.
94
112. Jamie WE, Edwards RK, Duff P. Vaginal-perianal compared with vaginal-rectal cultures for identification of group B streptococci. Obstet Gynecol 2004;104(5 Pt 1):1058–61.
113. Mercer BM, Taylor MC, Fricke JL, Baselski VS, Sibai BM. The accuracy and patient preference for self-collected group B streptococcus cultures. Am J Obstet Gynecol 1995;173:1325–8.
114. Price D, Shaw E, Howard M, Zazulak J, Waters H, Kaczorowski J. Self-sampling for group B Streptococcus in women 35 to 37 weeks pregnant is accurate and acceptable:
a randomized cross-over trial. J Obstet Gynaecol Can 2006;28:1083–8.
115. Arya A, Cryan B, O’Sullivan K, Greene RA, Higgins JR. Self-collected versus health professional-collected genital swabs to identify the prevalence of group B Streptococcus: a comparison of patient preference and efficacy. Eur J Obstet, Gynecol Reprod Biol 2008;139:43–5.
116. Teese N, Henessey D, Pearce C, Kelly N, Garland S. Screening protocols for group B Streptococcus: are transport media appropriate? Infect Dis Obstet Gynecol 2003;11:199–202.
117. Crisp BJ, Yancey MK, Uyehara C, Nauschuetz WF. Effect of delayed inoculation of selective media in antenatal detection of group B streptococci. Obstet Gynecol 1998;92:923–5.
118. Ostroff RM, Steaffens JW. Effect of specimen storage, antibiotics, and feminine hygiene products on the detection of group B Streptococcus by culture and the strep B OIA test. Diagn Microbiol Infect Dis 1995;22:253–9.
119. Stoner KA, Rabe LK, Hillier SL. Effect of transport time, temperature, and concentration on the survival of group B streptococci in Amies transport medium. J Clin Microbiol 2004;42:5385–7.
95
120. Rosa-Fraile M, Camacho-Munoz E, Rodriguez-Granger J, Liebana-Martos C.
Specimen storage in transport medium and detection of group B streptococci by culture.
J Clin Microbiol 2005;43:928–30.
121. Altaie SS, Dryja D. Detection of group B Streptococcus. Comparison of solid and liquid culture media with and without selective antibiotics. Diagn Microbiol Infect Dis 1994;18:141–4.
122. MacfFaddin J. Media for isolation-cultivation-identification-maintenance of medical bacteria. Baltimore, MD: Williams & Wilkins; 1985.
123. Rosa-Fraile M, Rodrguez-Granger J, Haidour-Benamin A, Cuerva J, Sampedro A.
Granadaene: proposed structure of the group B Streptococcus polyenic pigment. Appl Environ Microbiol 2006;72:6367–70.
124. Church DL, Baxter H, Lloyd T, Miller B, Elsayed S. Evaluation of StrepB carrot broth versus Lim broth for detection of group B Streptococcus colonization status of near-term pregnant women. J Clin Microbiol 2008;46:2780–2.
125. Martinho F, Prieto E, Pinto D, et al. Evaluation of liquid biphasic Granada medium and instant liquid biphasic Granada medium for group B Streptococcus detection. Enferm Infecc Microbiol Clin 2008;26:69–71.
126. Adler A, Block C, Engelstein D, Hochner-Celnikcier D, Drai-Hassid R, Moses AE.
Culture-based methods for detection and identification of Streptococcus agalactiae in pregnant women—what are we missing? Eur J Clin Microbiol Infect Dis 2008;27:241–
3.
127. Smith D, Perry J, Laine L, Galloway A, Gould FK. Comparison of BD GeneOhm real-time polymerase chain reaction with chromogenic and conventional culture methods for detection of group B Streptococcus in clinical samples. Diagn Microbiol Infect Dis2008;61:369–72.
96
128. Carvalho MD, Facklam R, Jackson D, Beall B, McGee L. Evaluation of three commercial broth media for pigment detection and identification of group B streptococci (GBS), Streptococcus agalactiae. J Clin Microbiol 2009;47:4161–3.
129. Wilkinson HW. CAMP-disk test for presumptive identification of group B streptococci. J Clin Microbiol 1977;6:42–5.
130. Guerrero C, Martinez J, Menasalvas A, Blazquez R, Rodriguez T, Segovia M. Use of direct latex agglutination testing of selective broth in the detection of group B streptococcal carriage in pregnant women. Eur J Clin Microbiol Infect Dis 2004;23:61–
2.
131. Votava M, Tejkalov M, Drbkov M, Unzeitig V, Braveny I. Use of GBS media for rapid detection of group B streptococci in vaginal and rectal swabs from women in labor. Eur J Clin Microbiol Infect Dis 2001;20:120–2.
132. Tazi A, Reglier-Poupet H, Dautezac F, Raymond J, Poyart C. Comparative evaluation of Strepto B ID chromogenic medium and Granada media for the detection of group B Streptococcus from vaginal samples of pregnant women. J Microbiol Methods 2008;73:263–5.
133. Montague N, Cleary T, Martinez O, Procop G. Detection of group B streptococci in Lim broth by use of group B Streptococcus peptide nucleic Acid fluorescent in situ hybridization and selective and nonselective agars. J Clin Microbiol 2008;46:3470–2.
134. Block T, Munson E, Culver A, Vaughan K, Hryciuk JE. Comparison of carrot broth- and selective Todd-Hewitt broth-enhanced PCR protocols for real-time detection of Streptococcus agalactiae in prenatal vaginal/anorectal specimens. J Clin Microbiol 2008;46:3615–20.
135. Davies HD, Miller MA, Faro S, Gregson D, Kehl SC, Jordan JA. Multicenter study of a rapid molecular-based assay for the diagnosis of group B Streptococcus colonization in pregnant women. Clin Infect Dis 2004;39:1129–35.